We are monitoring the impact of COVID-19 on Nuclear Imaging Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1543
Share on
Share on

Global Nuclear Imaging Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Application, Product, End-User & Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1543
Pages: 175

Global Nuclear Imaging Market Size (2021 to 2026)

The size of the global nuclear imaging market is estimated to value USD 19.80 billion by 2026 from USD 12.94 billion in 2021, growing at a CAGR of 8.87% during the forecast period.

The global nuclear imaging market growth is primarily driven by factors such as an increase in the prevalence of cancer globally and rising cardiac alignments. Hybrid imaging includes two or more modalities to form a new technique; hence hybrid modalities replaced the standalone modalities it is expected to propel the market growth. Personalized medicine is an emerging practice of medicine; it includes an individual’s genetic profile to lead to the decision related to prevention, hence increasing focussing on personalized treatments is expected to boost the market growth. 

Moreover, investments by government and private organizations partnerships to modernize diagnostic imaging centers. Besides, technological advancements and rising diagnostic applications in various diseases are projected to improve market growth. Researchers, scientists, and technologists bringing systems into clinical practice are considered to expand the market growth over the period. It is proved that diagnosing with nuclear imaging techniques impacts patient management for monitoring tumors and their drug response.

Nuclear imaging equipment pricing and installation required large capital, and investments cannot be affordable by the hospitals in rural areas, which is considered the major restraining factor for market growth. Healthcare facilities in developing countries such as India cannot afford such systems; these higher costs are coupled with the maintenance costs expected to impede the market growth. Healthcare provider purchases costly systems often depend on the reimbursement on the expenditure incurred, but sometimes continuous cuts in the reimbursement on diagnostic imaging scans prevent small and medium healthcare facilities from investing advance technological nuclear imaging modalities.

Impact of COVID-19 on the global nuclear imaging market:

SARS-COV-2, When the virus was first identified in Wuhan, China, the World health organization declared healthcare emergence. The World Health Organization (WHO) announced guidelines in order not to get affected by the COVID-19. A nationwide lockdown in multiple countries had been implemented to combat the COVID-19, and a ban was made on transportation. The partial shutdown of activities was made during the pandemic period.

The outbreak had mostly affected almost all sectors of the economy, including healthcare and life sciences markets. The covid-19 epidemic has impacted the availability of resources globally. Reduced patient visits and outpatient services for other diseases negatively affected the nuclear imaging market.

It is observed that both diagnostic and therapeutic nuclear medicine procedures had declined drastically as the world focused on combat with the SARS-COV-2. It is essential to have better knowledge for medical professionals of precautionary measures to prevent the transmission of COVID-19. The factors such as extreme health risks like diabetes, hypertension, lung diseases, and chronic renal are highly vulnerable to developing the COVID-19, which is held to decrease nuclear imaging procedures. However, in the later period, the market is expected to have better growth for the atomic imaging market.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Analysed

By Application, Product, End User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the global nuclear imaging market has been segmented and sub-segmented based on the product, application, end-user, and region.

Nuclear Imaging Market – By Product:

  • Standalone PET Nuclear Imaging
  • Standalone SPECT Nuclear Imaging
  • Hybrid Nuclear Imaging

Nuclear Imaging Market - By Application:

  • Oncology
  • Cardiology
  • Neurology
  • Others

Nuclear Imaging Market – By End User:

  • Hospitals
  • Diagnostic Centers
  • Research Centers

Nuclear Imaging Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America held the highest share in the global nuclear imaging market in 2019. It is expected to grow USD 2.7 billion in 2025, growing at an increasing CAGR of 4.1% during the forecast period. In this regional market, the U.S is estimated to account for the leading share in the next five years due to growing healthcare infrastructure and favorable reimbursement policies. Simultaneously, the U.S. accounted for the largest share in the global Nuclear Imaging market in 2019, as it spends nearly 20% of its GDP on health. Y-O-Y growth in the prevalence of cancer in the U.S. further adds a boost to the growth rate of the regional market. On the other hand, the Canadian market is witnessed to showcase healthy growth during the forecast period.

The European market was the second-largest regional market globally in 2019 and is estimated to grow at a CAGR of 11.4% between 2020 to 2025. Increasing healthcare expenditure and technological innovations are majorly attributing to the market growth in Europe. Increasing prevalence of chronic and cardiovascular diseases contributing to the market growth in this region. In Europe, U.K. held the majority share in this region in 2019, and it is forecasted to share a lucrative share to the European market.

However, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to reasons such as the growing geriatric populace and surge in the chronic disease population. This regional market is expected to be worth USD 2.43 billion by 2025 at an increasing CAGR of 14.3%. Emerging countries like India, China, Japan are significantly contributing to the APAC market, and the support is likely to continue throughout the forecast period. The rising geriatric population is one of the factors propelling the market in the Asia Pacific region.

The Middle East and Africa nuclear imaging market witnessed significant market growth in 2019, and it is projected to increase during the forecast period. An increase in atomic imaging usage for cardiovascular and oncology applications and public and private investments for improving the infrastructure in this region is estimated to propel the market growth over the forecast period.

KEY MARKET PLAYERS:

Companies leading the global nuclear imaging market profiled in the report are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Diagnostic Technologies        

                                5.1.1 Introduction

                                5.1.2 PET Radioisotopes

                                5.1.3 SPECT Radioisotopes

                                5.1.4 Y-o-Y Growth Analysis, By Diagnostic Technologies

                                5.1.5 Market Attractiveness Analysis, By Diagnostic Technologies

                                5.1.6 Market Share Analysis, By Diagnostic Technologies

                5.2 Application 

                                5.2.1 Introduction

                                5.2.2 PET

                                5.2.3 SPECT

                                5.2.4 Y-o-Y Growth Analysis, By Application

                                5.2.5 Market Attractiveness Analysis, By Application

                                5.2.6 Market Share Analysis, By Application

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis

                                6.1.5 Market Share Analysis

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Mallinckrodt plc        

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 Siemens Medical Solutions  

                8.3 Hitachi Medical Corporation

                8.4 Medtronic Inc.          

                8.5 General Electric Co. (healthcare division)       

                8.6 IBA Group   

                8.7 Positron Corporation              

                8.8 Philips Medical Systems        

                8.9 Naviscan      

                8.10 Toshiba Medical Systems Corporation          

                8.11 Carestream Health

                8.12 Lantheus Medical Imaging Inc.         

                8.13 Cardinal Health Inc.              

                8.14 Bayer AG  

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Nuclear Imaging Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  3. Global PET Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  5. Global Rubidium-82 Market, By Region, From 2021 to 2026 (USD Billion)
  6. Global Fluorine-18 Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Other PET radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global SPECT Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  10. Global Thallium-201 Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global Technetium-99m Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Xenon-133 Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Iodine-123 Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Other SPECT radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  15. Global Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  16. Global PET Market, By Region, From 2021 to 2026 (USD Billion)
  17. Global Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  18. Global Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  19. Global Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  20. Global Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  21. Global Other PET applications Market, By Region, From 2021 to 2026 (USD Billion)
  22. Global SPECT Market, By Region, From 2021 to 2026 (USD Billion)
  23. Global Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  24. Global Lymphoma Market, By Region, From 2021 to 2026 (USD Billion)
  25. Global Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  26. Global Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  27. Global Thyroid Market, By Region, From 2021 to 2026 (USD Billion)
  28. Global Other SPECT applications Market, By Region, From 2021 to 2026 (USD Billion)
  29. North America Nuclear Imaging Market, By Region, From 2021 to 2026 (USD Billion)
  30. North America Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  31. North America PET Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  32. North America Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  33. North America Rubidium-82 Market, By Region, From 2021 to 2026 (USD Billion)
  34. North America Fluorine-18 Market, By Region, From 2021 to 2026 (USD Billion)
  35. North America Other PET radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  36. North America SPECT Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  37. North America Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  38. North America Thallium-201 Market, By Region, From 2021 to 2026 (USD Billion)
  39. North America Technetium-99m Market, By Region, From 2021 to 2026 (USD Billion)
  40. North America Xenon-133 Market, By Region, From 2021 to 2026 (USD Billion)
  41. North America Iodine-123 Market, By Region, From 2021 to 2026 (USD Billion)
  42. North America Other SPECT radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  43. North America Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  44. North America PET Market, By Region, From 2021 to 2026 (USD Billion)
  45. North America Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  46. North America Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  47. North America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  48. North America Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  49. North America Other PET applications Market, By Region, From 2021 to 2026 (USD Billion)
  50. North America SPECT Market, By Region, From 2021 to 2026 (USD Billion)
  51. North America Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  52. North America Lymphoma Market, By Region, From 2021 to 2026 (USD Billion)
  53. North America Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  54. North America Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  55. North America Thyroid Market, By Region, From 2021 to 2026 (USD Billion)
  56. North America Other SPECT applications Market, By Region, From 2021 to 2026 (USD Billion)
  57. United States Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  58. United States Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  59. United States Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  60. United States Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  61. United States Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  62. United States Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  63. Canada Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  64. Canada Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  65. Canada Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  66. Canada Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  67. Canada Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  68. Canada Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  69. Europe Nuclear Imaging Market, By Region, From 2021 to 2026 (USD Billion)
  70. Europe Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  71. Europe PET Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  72. Europe Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  73. Europe Rubidium-82 Market, By Region, From 2021 to 2026 (USD Billion)
  74. Europe Fluorine-18 Market, By Region, From 2021 to 2026 (USD Billion)
  75. Europe Other PET radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  76. Europe SPECT Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  77. Europe Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  78. Europe Thallium-201 Market, By Region, From 2021 to 2026 (USD Billion)
  79. Europe Technetium-99m Market, By Region, From 2021 to 2026 (USD Billion)
  80. Europe Xenon-133 Market, By Region, From 2021 to 2026 (USD Billion)
  81. Europe Iodine-123 Market, By Region, From 2021 to 2026 (USD Billion)
  82. Europe Other SPECT radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  83. Europe Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  84. Europe PET Market, By Region, From 2021 to 2026 (USD Billion)
  85. Europe Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  86. Europe Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  87. Europe Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  88. Europe Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  89. Europe Other PET applications Market, By Region, From 2021 to 2026 (USD Billion)
  90. Europe SPECT Market, By Region, From 2021 to 2026 (USD Billion)
  91. Europe Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  92. Europe Lymphoma Market, By Region, From 2021 to 2026 (USD Billion)
  93. Europe Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  94. Europe Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  95. Europe Thyroid Market, By Region, From 2021 to 2026 (USD Billion)
  96. Europe Other SPECT applications Market, By Region, From 2021 to 2026 (USD Billion)
  97. U.K Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  98. U.K Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  99. U.K Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  100. U.K Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  101. U.K Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  102. U.K Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  103. Spain Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  104. Spain Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  105. Spain Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  106. Spain Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  107. Spain Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  108. Spain Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  109. Germany Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  110. Germany Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  111. Germany Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  112. Germany Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  113. Germany Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  114. Germany Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  115. Italy Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  116. Italy Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  117. Italy Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  118. Italy Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  119. Italy Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  120. Italy Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  121. France Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  122. France Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  123. France Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  124. France Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  125. France Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  126. France Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  127. Asia-Pacific Nuclear Imaging Market, By Region, From 2021 to 2026 (USD Billion)
  128. Asia-Pacific Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  129. Asia-Pacific PET Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  130. Asia-Pacific Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  131. Asia-Pacific Rubidium-82 Market, By Region, From 2021 to 2026 (USD Billion)
  132. Asia-Pacific Fluorine-18 Market, By Region, From 2021 to 2026 (USD Billion)
  133. Asia-Pacific Other PET radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  134. Asia-Pacific SPECT Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  135. Asia-Pacific Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  136. Asia-Pacific Thallium-201 Market, By Region, From 2021 to 2026 (USD Billion)
  137. Asia-Pacific Technetium-99m Market, By Region, From 2021 to 2026 (USD Billion)
  138. Asia-Pacific Xenon-133 Market, By Region, From 2021 to 2026 (USD Billion)
  139. Asia-Pacific Iodine-123 Market, By Region, From 2021 to 2026 (USD Billion)
  140. Asia-Pacific Other SPECT radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  141. Asia-Pacific Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  142. Asia-Pacific PET Market, By Region, From 2021 to 2026 (USD Billion)
  143. Asia-Pacific Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  144. Asia-Pacific Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  145. Asia-Pacific Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  146. Asia-Pacific Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  147. Asia-Pacific Other PET applications Market, By Region, From 2021 to 2026 (USD Billion)
  148. Asia-Pacific SPECT Market, By Region, From 2021 to 2026 (USD Billion)
  149. Asia-Pacific Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  150. Asia-Pacific Lymphoma Market, By Region, From 2021 to 2026 (USD Billion)
  151. Asia-Pacific Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  152. Asia-Pacific Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  153. Asia-Pacific Thyroid Market, By Region, From 2021 to 2026 (USD Billion)
  154. Asia-Pacific Other SPECT applications Market, By Region, From 2021 to 2026 (USD Billion)
  155. China Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  156. China Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  157. China Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  158. China Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  159. China Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  160. China Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  161. India Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  162. India Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  163. India Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  164. India Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  165. India Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  166. India Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  167. Japan Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  168. Japan Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  169. Japan Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  170. Japan Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  171. Japan Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  172. Japan Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  173. South Korea Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  174. South Korea Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  175. South Korea Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  176. South Korea Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  177. South Korea Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  178. South Korea Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  179. Australia Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  180. Australia Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  181. Australia Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  182. Australia Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  183. Australia Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  184. Australia Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  185. Latin America Nuclear Imaging Market, By Region, From 2021 to 2026 (USD Billion)
  186. Latin America Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  187. Latin America PET Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  188. Latin America Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  189. Latin America Rubidium-82 Market, By Region, From 2021 to 2026 (USD Billion)
  190. Latin America Fluorine-18 Market, By Region, From 2021 to 2026 (USD Billion)
  191. Latin America Other PET radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  192. Latin America SPECT Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  193. Latin America Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  194. Latin America Thallium-201 Market, By Region, From 2021 to 2026 (USD Billion)
  195. Latin America Technetium-99m Market, By Region, From 2021 to 2026 (USD Billion)
  196. Latin America Xenon-133 Market, By Region, From 2021 to 2026 (USD Billion)
  197. Latin America Iodine-123 Market, By Region, From 2021 to 2026 (USD Billion)
  198. Latin America Other SPECT radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  199. Latin America Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  200. Latin America PET Market, By Region, From 2021 to 2026 (USD Billion)
  201. Latin America Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  202. Latin America Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  203. Latin America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  204. Latin America Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  205. Latin America Other PET applications Market, By Region, From 2021 to 2026 (USD Billion)
  206. Latin America SPECT Market, By Region, From 2021 to 2026 (USD Billion)
  207. Latin America Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  208. Latin America Lymphoma Market, By Region, From 2021 to 2026 (USD Billion)
  209. Latin America Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  210. Latin America Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  211. Latin America Thyroid Market, By Region, From 2021 to 2026 (USD Billion)
  212. Latin America Other SPECT applications Market, By Region, From 2021 to 2026 (USD Billion)
  213. Brazil Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  214. Brazil Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  215. Brazil Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  216. Brazil Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  217. Brazil Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  218. Brazil Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  219. Argentina Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  220. Argentina Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  221. Argentina Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  222. Argentina Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  223. Argentina Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  224. Argentina Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  225. Mexico Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  226. Mexico Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  227. Mexico Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  228. Mexico Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  229. Mexico Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  230. Mexico Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  231. Middle East & Africa Nuclear Imaging Market, By Region, From 2021 to 2026 (USD Billion)
  232. Middle East & Africa Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  233. Middle East & Africa PET Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  234. Middle East & Africa Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  235. Middle East & Africa Rubidium-82 Market, By Region, From 2021 to 2026 (USD Billion)
  236. Middle East & Africa Fluorine-18 Market, By Region, From 2021 to 2026 (USD Billion)
  237. Middle East & Africa Other PET radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  238. Middle East & Africa SPECT Radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  239. Middle East & Africa Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  240. Middle East & Africa Thallium-201 Market, By Region, From 2021 to 2026 (USD Billion)
  241. Middle East & Africa Technetium-99m Market, By Region, From 2021 to 2026 (USD Billion)
  242. Middle East & Africa Xenon-133 Market, By Region, From 2021 to 2026 (USD Billion)
  243. Middle East & Africa Iodine-123 Market, By Region, From 2021 to 2026 (USD Billion)
  244. Middle East & Africa Other SPECT radioisotopes Market, By Region, From 2021 to 2026 (USD Billion)
  245. Middle East & Africa Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  246. Middle East & Africa PET Market, By Region, From 2021 to 2026 (USD Billion)
  247. Middle East & Africa Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  248. Middle East & Africa Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  249. Middle East & Africa Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  250. Middle East & Africa Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  251. Middle East & Africa Other PET applications Market, By Region, From 2021 to 2026 (USD Billion)
  252. Middle East & Africa SPECT Market, By Region, From 2021 to 2026 (USD Billion)
  253. Middle East & Africa Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  254. Middle East & Africa Lymphoma Market, By Region, From 2021 to 2026 (USD Billion)
  255. Middle East & Africa Neurology Market, By Region, From 2021 to 2026 (USD Billion)
  256. Middle East & Africa Cardiology Market, By Region, From 2021 to 2026 (USD Billion)
  257. Middle East & Africa Thyroid Market, By Region, From 2021 to 2026 (USD Billion)
  258. Middle East & Africa Other SPECT applications Market, By Region, From 2021 to 2026 (USD Billion)
  259. Middle East Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  260. Middle East Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  261. Middle East Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  262. Middle East Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  263. Middle East Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  264. Middle East Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)
  265. Africa Nuclear Imaging Market, By Diagnostic Technologies , From 2021 to 2026 (USD Billion)
  266. Africa Nuclear Imaging Market, By PET Radioisotopes, From 2021 to 2026 (USD Billion)
  267. Africa Nuclear Imaging Market, By SPECT Radioisotopes, From 2021 to 2026 (USD Billion)
  268. Africa Nuclear Imaging Market, By Application, From 2021 to 2026 (USD Billion)
  269. Africa Nuclear Imaging Market, By PET, From 2021 to 2026 (USD Billion)
  270. Africa Nuclear Imaging Market, By SPECT, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample